Literature DB >> 1166383

Oophorectomy for advanced carcinoma of the breast.

U Veronesi, G Pizzocaro, A Rossi.   

Abstract

From 1960 to 1972, 639 patients have undergone bilateral oophorectomy for carcinoma of the breast. The over-all regression rate was 29.5 per cent; regressions lasted on an average of 16 months, and 19 per cent of the patients who responded to surgical castration survived five years or longer. The best results were achieved when the patients were premenopausal and over 35 years of age or not more than one year menopausal, if the free interval was longer than two years or if the patient had primary advanced carcinoma and when the lesions were localized to the soft tissues, bones, lung and pleura. Attempts to demonstrate the hormone-dependence of the tumor by correlating the response rate to preoperative urinary steroid determination or by cytologic examination of the vaginal smear were inconclusive.

Entities:  

Mesh:

Year:  1975        PMID: 1166383

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  7 in total

1.  Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy.

Authors:  U Veronesi; B Salvadori; A Luini; A Banfi; R Zucali; M Del Vecchio; R Saccozzi; E Beretta; P Boracchi; G Farante
Journal:  Ann Surg       Date:  1990-03       Impact factor: 12.969

2.  Tamoxifen (Nolvadex) for premenopausal patients with advanced breast cancer.

Authors:  R Margreiter; J Wiegele
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

3.  Bilateral ovariectomy in premenopausal patients with advanced breast cancer, after the evaluation of estrogen receptors and urinary androgen excretion.

Authors:  S Oriana; G Secreto; A Severini; G Di Fronzo; M Di Giuseppe; P Valagussa; F Preda
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

Review 4.  New generation aromatase inhibitors in breast cancer. Weighing out potential costs and benefits.

Authors:  G M Higa
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

5.  A reappraisal of oophorectomy in carcinoma of the breast.

Authors:  U Veronesi; N Cascinelli; M Greco; G Di Fronzo; R Oriana; M Merson; D Galluzzo; R Bufalino; F Belli; V Sacchini
Journal:  Ann Surg       Date:  1987-01       Impact factor: 12.969

6.  Urinary androgens and tumor estrogen receptor as predictors of ovariectomy response and of survival in advanced breast cancer.

Authors:  S Oriana; G Secreto; G Di Fronzo; A Torri
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

Review 7.  Endocrine Therapy in Premenopausal Hormone Receptor Positive/Human Epidermal Growth Receptor 2 Negative Metastatic Breast Cancer: Between Guidelines and Literature.

Authors:  Richard Tancredi; Jenny Furlanetto; Sibylle Loibl
Journal:  Oncologist       Date:  2018-06-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.